Growth Stocks To Research - October 22nd

Key Points

• Teledyne Technologies, Prologis, and Ascendis Pharma A/S are identified as key growth stocks to monitor due to their high trading volumes and potential for above-average revenue growth.
• Teledyne Technologies specializes in industrial growth technologies and includes a diverse range of digital imaging solutions.
• Prologis is a leader in logistics real estate, managing approximately 1.2 billion square feet of property across 19 countries.

Teledyne Technologies, Prologis, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to generate above‑average revenue and earnings growth, so investors buy them mainly for capital appreciation rather than current income. They often reinvest profits instead of paying dividends and trade at higher valuations and greater volatility because prices reflect optimistic future growth expectations. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND